disitamab vedotin
RC48G001
Phase 2 small_molecule active
Quick answer
disitamab vedotin for Urothelial Carcinoma is a Phase 2 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Urothelial Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active